Altimmune (ALT) Enterprise Value Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Altimmune | 379.61 Mn | 379.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.85% |
| Dec 31, 2025 | -638.87% |
| Sep 30, 2025 | -51.21% |
| Jun 30, 2025 | -11.03% |
| Mar 31, 2025 | 17.68% |
| Dec 31, 2024 | 72.63% |
| Sep 30, 2024 | -60.37% |
| Jun 30, 2024 | -3.10% |
| Mar 31, 2024 | -9.83% |
| Dec 31, 2023 | -21.62% |
| Sep 30, 2023 | 31.83% |
| Jun 30, 2023 | -17.71% |
| Mar 31, 2023 | 7.92% |
| Dec 31, 2022 | 41.61% |
| Sep 30, 2022 | 36.21% |
| Jun 30, 2022 | 37.61% |
| Mar 31, 2022 | 20.54% |
| Dec 31, 2021 | 11.85% |
| Sep 30, 2021 | -39.25% |
| Jun 30, 2021 | -171.44% |
| Mar 31, 2021 | -587.46% |
| Dec 31, 2020 | -479.37% |
| Sep 30, 2020 | -265.93% |
| Jun 30, 2020 | -92.29% |
| Mar 31, 2020 | 27.69% |
| Dec 31, 2019 | -6.54% |
| Sep 30, 2019 | -388.43% |
| Jun 30, 2019 | -679.60% |
| Mar 31, 2019 | -291.89% |
| Dec 31, 2018 | -120.91% |
| Sep 30, 2018 | 53.26% |
| Jun 30, 2018 | 36.53% |
| Mar 31, 2018 | -324.74% |
| Dec 31, 2017 | 77.27% |
| Sep 30, 2017 | 87.36% |
| Jun 30, 2017 | 63.57% |
| Mar 31, 2017 | 80.77% |
| Dec 31, 2016 | -1,402.29% |
| Sep 30, 2016 | -681.79% |
| Jun 30, 2016 | -25.78% |
| Mar 31, 2016 | 9.47% |
| Dec 31, 2015 | 75.12% |
| Sep 30, 2015 | 11.37% |
| Jun 30, 2015 | -63.44% |
| Mar 31, 2015 | -64.92% |
| Dec 31, 2014 | -77.88% |
| Sep 30, 2014 | -23.06% |
| Jun 30, 2014 | 28.66% |
| Mar 31, 2014 | 25.93% |
| Dec 31, 2013 | 17.48% |
| Sep 30, 2013 | -8.26% |
| Jun 30, 2013 | -34.08% |
| Mar 31, 2013 | 15.88% |
| Dec 31, 2012 | -13.04% |
| Sep 30, 2012 | -41.52% |
| Jun 30, 2012 | 16.83% |
| Mar 31, 2012 | -57.64% |
| Dec 31, 2011 | 4.65% |
| Sep 30, 2011 | -282.89% |
| Jun 30, 2011 | -1,976.33% |